Romiplostim Data Show Potential Long-Term Efficacy and Safety
- Details
- Category: Amgen

Pfizer Celebrates 5 Years of High-Impact Corporate Volunteer Missions
- Details
- Category: Pfizer

Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.
- Details
- Category: Pfizer

First positive health technology assessments for novel oral anticoagulant Pradaxa®
- Details
- Category: Boehringer Ingelheim

GlaxoSmithKline acquires Sirtris Pharmaceuticals, Inc.
- Details
- Category: GlaxoSmithKline

Nycomed sells oncology programs to 4SC
- Details
- Category: Nycomed

Bayer HealthCare Commits US-Dollar 2.5 Million in Funding to Advance Global Hemophilia Research
- Details
- Category: Bayer

More Pharma News ...
- Novo Nordisk and Neose announce completion of initial phase 1 clinical trial of NN7128
- Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR
- Bristol-Myers Squibb Pharma EEIG withdraws its marketing authorisation application for DuoCover
- Sanofi Pharma Bristol-Myers Squibb SNC withdraws its marketing authorisation for DuoPlavin
- Amgen Posts Medical Education and Foundation Grants and Donations
- High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass Surgery Patients
- A promising start into 2008 for Nycomed